Vaccine
Vaccine
  • Clinical Insights

Preparing for the COVID-19 Vaccine

Dec 22nd, 2020

Learn How Your Organization Can Prepare for the COVID-19 Vaccine

Click above to read the guide.

As of mid-December 2020, more than 72 million cases of COVID-19 have been recorded worldwide, leading to over 1.6 million deaths.

The development of effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, has been anxiously anticipated since the onset of the pandemic, and the recent distribution of two vaccines brings hope to—and questions from—health care organizations.

Health care organizations, including long-term care facilities and behavioral health centers, are closely monitoring the development and distribution of vaccines. On their minds: protecting both their front-line health care workers and their consumers, many of them living with chronic, complex health conditions.

Read this guide to learn about the status of the most promising vaccines in development or currently available, and how and when distribution is likely to occur.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
4 things to know about Spravato® (Intranasal esketamine)

On January 21, 2025, the FDA announced the approval of Spravato® nasal spray as a monotherapy treatment for treatment-resistant depression (TRD), making this medication the first and only monotherapy option...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa’s 2024 Art Celebration: Celebrating the healing power of creativity

“I’ve always expressed myself through my art and learned to use my creativity to inspire others”, says Genoa Healthcare 2024 Art Celebration participant Shanelle G. Genoa’s annual Art Celebration invites...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Esketamine: Latest research offers new hope for adolescents with treatment-resistant depression

Adolescents with treatment-resistant depression (TRD) often struggle with a lack of effective treatment options. While ketamine has been shown to help improve outcomes for adults living with major depressive disorder...

  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...